TERT-BUTYL 4-FLUORO-3-OXOAZEPANE-1-CARBOXYLATE, 95.0%, 500mg

N-(4-Bromo-2-chloro-6-methylphenyl)acetamide, 98%, 250mg

(4'-Chloro-biphenyl-4-yl)-acetic acid, 95.0%, 5g

(2R)-8-chloro-2-(trifluoromethyl)-2H,3H,4H,6H,7H-[1,3]diazino[1,2-a]pyrimidin-6-one, 98%, 1g

Dibenzo[b,d]thiophen-2-amine, 97%, 100mg

Methyl (4aS,4bS,6aS,7S,9aS,9bS,11aR)-3-fluoro-1,4a,6a-trimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylate, 98%, 100mg

2-Chloro-8-fluoroquinoline, 95.0%, 10g

Dialysis membrane Spectra/Por® 6 MWCO 50,000 (opaque), 34 mm, 1 Piece(s)

METHYL 5-CYANO-6-OXO-1,6-DIHYDROPYRIDINE-3-CARBOXYLATE, 95.0%, 500mg

Bismuth(III) Chloride>97.0%(T)250g

2,3-Difluorobenzyl alcohol, 95.0%, 5g

Volumetric flasks with glass stopper, class A Clear glass, 5 ml, 10/19, 2 Piece(s)

N-Benzylethylenediamine>97.0%(GC)25mL